auto-fix: strip 4 broken wiki links
Pipeline auto-fixer: removed [[ ]] brackets from links that don't resolve to existing claims in the knowledge base.
This commit is contained in:
parent
a8c1a71fdc
commit
ad56f8b13a
3 changed files with 4 additions and 4 deletions
|
|
@ -64,4 +64,4 @@ Relevant Notes:
|
|||
- [[healthcare is a complex adaptive system requiring simple enabling rules not complicated management because standardized processes erode the clinical autonomy needed for value creation]]
|
||||
|
||||
Topics:
|
||||
- [[domains/health/_map]]
|
||||
- domains/health/_map
|
||||
|
|
|
|||
|
|
@ -56,7 +56,7 @@ For US policy debates, the NHS is ammunition against both extremes:
|
|||
Relevant Notes:
|
||||
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
|
||||
- [[gatekeeping systems optimize primary care at the expense of specialty access creating structural bottlenecks]]
|
||||
- gatekeeping systems optimize primary care at the expense of specialty access creating structural bottlenecks
|
||||
|
||||
Topics:
|
||||
- [[domains/health/_map]]
|
||||
- domains/health/_map
|
||||
|
|
|
|||
|
|
@ -19,7 +19,7 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
|
|||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2014-00-00-aspe-pace-effect-costs-nursing-home-mortality]] | Added: 2026-03-10 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
*Source: 2014-00-00-aspe-pace-effect-costs-nursing-home-mortality | Added: 2026-03-10 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
|
||||
PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
|
||||
|
||||
|
|
|
|||
Loading…
Reference in a new issue